Professor Ben Fisher

Ben Fisher is a Professor in Clinical Rheumatology at the University of Birmingham. He has published research papers on Sjögren’s syndrome and inflammatory arthritis and has participated in many national and international collaborations.

Ben is part of a team who designed the recent COVID-19 drugs trial ‘CATALYST’, which rapidly tests new therapies for patients hospitalised due to COVID-19. It is hoped that by using drugs that target the most serious symptoms of the virus, the severity of the disease could be reduced leading to a reduction in the number of patients needing to be admitted to intensive care and ultimately, a reduction in virus related deaths.